From the results of in vivo experiments (Fig. 4), it was found that intermittent administration of 2DG in combination with HAuNS-Met@MS could contribute the highest proportion of OVA-specific CD8+ T cells as well as CD8+ TCMs in the tumor tissues of mice, and even significantly inhibited the primary tumor and metastasis. This evidence concerns the gene CD8A and neoplasm.